These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3800492

  • 21. Single-dose pharmacokinetics of daptomycin in young and geriatric volunteers.
    Dvorchik B, Damphousse D.
    J Clin Pharmacol; 2004 Jun; 44(6):612-20. PubMed ID: 15145969
    [Abstract] [Full Text] [Related]

  • 22. Attenuation of furosemide's diuretic effect by indomethacin: pharmacokinetic evaluation.
    Smith DE, Brater DC, Lin ET, Benet LZ.
    J Pharmacokinet Biopharm; 1979 Jun; 7(3):265-74. PubMed ID: 480148
    [Abstract] [Full Text] [Related]

  • 23. Clinical pharmacokinetics and pharmacodynamics of torasemide.
    Knauf H, Mutschler E.
    Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
    [Abstract] [Full Text] [Related]

  • 24. Hydralazine and furosemide kinetics.
    Nomura A, Yasuda H, Katoh K, Akimoto T, Miyazaki K, Arita T.
    Clin Pharmacol Ther; 1982 Sep; 32(3):303-6. PubMed ID: 7105621
    [Abstract] [Full Text] [Related]

  • 25. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M, Roberts C, Branch RA.
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [Abstract] [Full Text] [Related]

  • 26. Effects of high altitude exposure on the pharmacokinetics of furosemide in healthy volunteers.
    Arancibia A, Nella Gai M, Paulos C, Chávez J, Pinilla E, Angel N, Ritschel WA.
    Int J Clin Pharmacol Ther; 2004 Jun; 42(6):314-20. PubMed ID: 15222723
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M.
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [Abstract] [Full Text] [Related]

  • 28. Metabolic clearance of furosemide in the rat.
    Wallin JD, Ryals P, Kaplowitz N.
    J Pharmacol Exp Ther; 1977 Jan; 200(1):52-7. PubMed ID: 833762
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.
    Traeger A, Stein G, Sperschneider H, Keil E.
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766
    [Abstract] [Full Text] [Related]

  • 30. Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers.
    Nomeir AA, Radwanski E, Cutler D, Affrime M, Christopher D, Korduba C, Batra V, Lin CC, Cayen MN.
    J Clin Pharmacol; 1997 Nov; 37(11):1021-30. PubMed ID: 9505995
    [Abstract] [Full Text] [Related]

  • 31. The pharmacokinetics of furosemide in anaesthetized horses after bilateral ureteral ligation.
    Dyke TM, Hubbell JA, Grosenbaugh DA, Beard W, Mitten L, Sams RA, Hinchcliff KW.
    J Vet Pharmacol Ther; 1998 Aug; 21(4):298-303. PubMed ID: 9731952
    [Abstract] [Full Text] [Related]

  • 32. Role of binding in distribution of furosemide: where is nonrenal clearance?
    Branch RA.
    Fed Proc; 1983 Apr; 42(6):1699-702. PubMed ID: 6832389
    [Abstract] [Full Text] [Related]

  • 33. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T, Frohna P, Sun HL, Wolff A, Belardinelli L, Lieu H.
    Clin Pharmacokinet; 2006 Apr; 45(12):1201-12. PubMed ID: 17112296
    [Abstract] [Full Text] [Related]

  • 34. Pharmacodynamics and pharmacokinetics of the basic triamterene analogue dimethylaminohydroxypropoxytriamterene.
    Priewer H, Kraft H, Mutschler E.
    Arzneimittelforschung; 1985 Apr; 35(11):1688-91. PubMed ID: 4091871
    [Abstract] [Full Text] [Related]

  • 35. The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration.
    Chay S, Woods WE, Rowse K, Nugent TE, Blake JW, Tobin T.
    Drug Metab Dispos; 1983 Apr; 11(3):226-31. PubMed ID: 6135581
    [Abstract] [Full Text] [Related]

  • 36. Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.
    Riva E, Fossali E, Bettinelli A.
    Eur J Clin Pharmacol; 1982 Apr; 21(4):303-6. PubMed ID: 7056274
    [Abstract] [Full Text] [Related]

  • 37. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE, Nicholls AJ, Kamm BR.
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [Abstract] [Full Text] [Related]

  • 38. Furosemide kinetics in patients with hepatic cirrhosis with ascites.
    Fuller R, Hoppel C, Ingalls ST.
    Clin Pharmacol Ther; 1981 Oct; 30(4):461-7. PubMed ID: 7285480
    [Abstract] [Full Text] [Related]

  • 39. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF, Meyer M, Thelen K, Krauss M, Willmann S, Eissing T, Jaehde U.
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.
    Dumas M, de Gislain C, d'Athis P, Chadoint-Noudeau V, Escousse A, Guerrin J, Autissier N.
    Cancer Chemother Pharmacol; 1989 Dec; 23(1):37-40. PubMed ID: 2909288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.